Pagina 18 - I migliori medici di Risonanza magnetica di un'area - TOP-568medici

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Anton Wohl leads the Brain Tumors Unit at Sheba Medical Center (since 2026). He is a neurosurgeon specializing in neuro-oncology, brain tumor surgery, and stereotactic radiosurgery.

He performs complex tumor operations with intraoperative MRI and functional mapping. He also uses fluorescence guidance, neuronavigation, and awake craniotomy to help remove tumors safely and preserve function.

Accreditations: Israeli Board Certification in Neurosurgery; Israeli medical license; advanced international fellowships and training, including the Mayo Clinic (USA).

Research: author and co-author of peer-reviewed publications on glioblastoma, malignant brain tumors, radiosurgery, and experimental therapies.

Il medico è un ginecologo specializzato in operazioni endoscopiche e laparoscopiche. Con un focus sulle tecniche chirurgiche minimamente invasive, il medico è abile nell'eseguire procedure avanzate che migliorano il recupero e i risultati dei pazienti. Il medico ha una vasta esperienza nella gestione di casi ginecologici complessi, utilizzando tecnologie all'avanguardia per fornire cure ottimali.<\/p>

Dr. Shady Mohammed El‑sebai is an interventional radiologist and diagnostic imaging consultant. He is the Consultant and Chief of Interventional Radiology at Sheaf El Orman Oncology Hospital (2021–present). He is also Chief of the Interventional Radiology Unit at the National Cancer Institute, Cairo University (2022–present). He has been a Lecturer in interventional radiology at the National Cancer Institute since 2018. Earlier posts include assistant lecturer and specialist, radiology resident, specialist at Khartoum Breast Care Centre, and specialist and consultant at Techno Scan.

Expertise includes CT‑ and US‑guided true‑cut biopsies and FNAC; transarterial chemoembolization for HCC and for liver, renal, and soft‑tissue tumors; percutaneous nephrostomy and ureteric stents; pigtail drainage; and RF or microwave ablation of hepatic, bone, lung, and thyroid lesions. He also performs PTD and biliary stents; uterine artery embolization; coiling for pelvic varicosities and varicocele; varicose vein ablation and sclerotherapy; and breast procedures (biopsy, markers, wire localization, Mammotome). He is skilled in US, CT, and MRI.

General information

Musculoskeletal radiologist, expert in sports injuries and magnetic resonance imaging with over 20 years of experience working with professional and elite athletes.

Professional experience

• Founder : Elite Sports Imaging, SL, Madrid, Spain.
• Medical consultant : Madrid Open (tennis tournament).
• Consultant : Longwood MRI Specialists, Boston, USA.
• Director of Musculoskeletal MRI and CT : Massachusetts General Hospital/Harvard Medical School (2002–2006).

Education and qualifications

• University of California, Los Angeles (UCLA) : Bachelor of Science in Kinesiology and Exercise Science (BS).
• McGill University School of Medicine : Doctor of Medicine and Master of Surgery (MD, CM).
• Boston University/Boston Medical Center : Radiology Residency.
• Harvard Medical School/Massachusetts General Hospital : Fellowship in Musculoskeletal Radiology and Interventional Radiology.
• Massachusetts Institute of Technology (MIT)/m+Visión : Postdoctoral Fellowship in Biomedical Research in Medical Imaging.

Peculiarities of professional activity

The doctor specializes in:

• Diagnosis and treatment of sports injuries using MRI and CT.
• Implementation of advanced technologies in the field of visualization of the musculoskeletal system.
• A personalized approach to diagnosing injuries in elite athletes.

The doctor has exceptional experience working at leading global institutions such as Harvard Medical School and MIT, which allows him to combine clinical practice, scientific research and the application of innovative methods in medical imaging.

Il medico è un neurologo altamente esperto, con un focus sulla diagnosi e il trattamento di un'ampia gamma di disturbi neurologici. Con oltre 15 anni di esperienza clinica, il medico ha contribuito a numerosi studi di ricerca ed è stato pubblicato in diverse riviste mediche prestigiose. Il medico è stato riconosciuto per approcci innovativi nella cura del paziente e ha ricevuto numerosi premi per l'eccellenza in neurologia. Inoltre, il medico è certificato dal consiglio e partecipa attivamente all'educazione medica continua per rimanere aggiornato con gli ultimi progressi nel campo.<\/p>

Il medico è specialista in chirurgia generale e viscerale, operando come chirurgo presso il Dipartimento di Chirurgia Generale dell'Università Medica di Vienna. Guidando il team di chirurgia gastrica ed esofagea, il medico è anche il Capo dell'Unità Tumori Gastroesofagei presso il Centro Oncologico Comprensivo di Vienna.<\/p>

Con oltre 240 articoli specializzati pubblicati, il medico ha ricoperto ruoli significativi come Segretario Generale della Società Austriaca di Oncologia Chirurgica dal 2014 e Capo del Servizio GI Superiore dal 2012. Il medico è Professore Associato di Chirurgia ed è specialista in chirurgia GI superiore dal 2007.<\/p>

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Personal information

Title: Associate Professor

Branch: Anesthesiology

Work History:

1 Gayrettepe Florence Nightingale Hospital

Medical Specialties and Subspecialties:

1 Waist and Neck Pain

2 Cancer Pains

3 Spine Pains

4 Pain

Education

1991 - Istanbul University Cerrahpaşa Faculty of Medicine

1996 - Istanbul University Cerrahpaşa Faculty of Medicine Anesthesia and Reanimation

Specialization Training

2017 - Fellow of Interventional Pain Practice

2018- Certifield Interventional Pain Sonologist

International Articles

1 ÇÖMLEK SAVAŞ, MUTLU AYHAN, ÖZGÖNENEL EBRU, KAHRAMAN SİNAN, ÖZGÖNENEL LEVENT (2021). Atypical Fem-oral Fracture After Discontinuing Long-Term Bisphosphonate Use. Demiroğlu Bilim University Florence Nightingale

Medical Journal, 7(1), 52-56., Doi: 10.5606/fng.btd.2021.25048

2 POTTERY WAR, ORDU AYLIN (2021). Interventional Pain Management During SARS-CoV-2 Pandemic. Signa Vitae, 17(4),

178-184., doi: 10.22514/sv.2021.008

3 SAVAS COMLEK(2021). Transverse Abdominis Plane Block-Based Multimodal Analgesia Protocol Reduces Tramadol

Need After Cesarean Section. Bağcılar Medical Bulletin, 6(2), 134-141., Doi: 10.4274/BMB.galenos.2021.11.077

4 ÇÖMLEK SAVAS, SAĞLAM SEZER (2021). A New Approach for Leptomeningeal Metastases: Chemotherapy Adminis-

tered Through Lumbar Intrathecal Port. Arquivos de Neuro-Psiquiatria, Doi: 10.1590/0004-282X-ANP-2020-0554

5 SAVAS COMLEK(2021). Treatment Methods for Bone Metastasis-Induced Pain. Turkish Journal of Oncology, 36(1), 73-

78., Doi: 10.5505/tjo.2021.S1019

6 SAVAS COMLEK(2021). Ultrasound-Guided Interventions During Pregnancy for Lumbosacral Pain Unresponsive to Con-

servative Treatment: A Retrospective Review. Journal of Clinical Ultrasound, 49(1), 20-27., Doi: 10.1002/jcu.22923

7 SAVAS COMLEK(2020). Pain Control with Splanchnic Neurolysis in Pancreatic Cancer Patients Unresponsive to Celiac

Plexus Neurolysis. Journal of Pain Research, 13, 2023-2031., doi: 10.2147/JPR.S266689

8 SAVAS COMLEK(2020). Chemotherapy-Induced Pneumonitis Associated with Transient CA 15-3 Elevation. Journal of

Oncology Pharmacy Practice, 26(7), 1750-1753., Doi: 10.1177/1078155220904994

9 RAHİMİ MEHDİ, GÖĞÜZ DEMET, KAYA GÜNER, BOZKURT PERVİN, ÇÖMLEK SAVAŞ (2000). Patient Controlled Analgesia

(PCA) Application in Pediatric Patients. Ağrı, 12(1), 19-26.

10 BOZKURT PERVİN, KAYA GÜNER, TUNALI YUSUF, ÇÖMLEK SAVAŞ (1996). Bradyarrhythmia During Reperfusion in Kidney Transplantations (Case Report). Journal of the Turkish Society of Anesthesiology and Reanimation, 24(2), 92-94.

Parkinson's Disease Diagnosis and Treatments

Alzheimer's Diagnosis and Treatments

Epilepsy (Epileptic)

EEG and Treatment

Muscle and Nerve Disease Diagnosis and Treatments

Vertigo Diagnosis and Treatment

Restless Leg Syndrome

Stroke (Cerebral Palsy) Diagnosis and Treatment

Bartın State Hospital (2007-2009)

VM Medical Park Samsun Hospital (2009-2017)

VM Medical Park Samsun Hospital - Deputy Chief Physician (2019-2021)

Samsun Education and Research Hospital (2021-2022)

Çarşamba State Hospital

Private Atasam Samsun Hospital (2022-2024)

Karadeniz Technical University (1989-1995)

Ondokuz Mayis University Faculty of Medicine (2001-2006)

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Education and Expertise

• DOKUZ EYLÜL UNIVERSITY FACULTY OF MEDICINE

Diseases

• Abdominal Radiology
• Advanced MRI Applications
• Breast Radiology

Experience

Private Medical Park Izmir Hospital (2016 - Ongoing)

Şifa University Bornova Health Application and Research Center (2012 - 2016)

Tütav Basmane Şifa Hospital (2008 - 2012)

Tütav Basmane Şifa Hospital (1995 - 2008)

Professional Memberships

• TURKISH RADIOLOGY ASSOCIATION

Interest Areas

Balloon Angioplasty (Opening of Vascular Narrowing with Balloon)

Basic Methods

Brain Angiography

General Radiology 4D Pregnancy Ultrasound Heart Angiography (Wrist)

Op. Dr. Ayhan Kara is a neurosurgeon with over 25 years in spine surgery. He specializes in minimally invasive and endoscopic procedures on the cervical and lumbar spine. His work includes anterior discectomy, nucleoplasty, and spinal instrumentation and fixation. He graduated from Dicle University. He completed neurosurgery training at Kartal Training and Research Hospital. He also finished an internship at Helios Clinic in Hamburg.

He has performed hundreds of advanced spine operations. He aims for fast recovery and shorter rehab. He stays active in courses and conferences. He uses current, individualized methods. Interests: minimally invasive and endoscopic spine surgery (cervical, lumbar), anterior lumbar discectomy, nucleoplasty, spinal instrumentation and fixation.

Assoc. Prof. Dr. Mehmet Salih İyikesici is a medical oncologist. He provides personalized care for breast, lung, and gastrointestinal cancers. He combines metabolically supported therapies with chemotherapy. His interests include the ketogenic diet in cancer care, hyperthermia, and hyperbaric oxygen therapy.

He has conducted and contributed to national and international scientific studies. Selected national peer-reviewed publications include Metabolic Supported Chemotherapy in Rectal Cancer (2020), NSCLC Patient Outcomes – Marmara University (2004), and Early-Stage Breast Cancer Outcomes (2004).